Jim J. Miller
Presidente en NDI Investment Management, Inc. .
Perfil
Jim J.
Miller was the founder of NDI Capital, Inc. (founded in 2003) where he held the title of Managing Partner in 2012.
Dr. Miller's current jobs include Chairman at NDI Investment Management, Inc. (since 2001) and Director at Gateway Income Trust.
Dr. Miller's former jobs include Chairman, President & Chief Executive Officer at QLT, Inc. (1981-1991), Chairman, President & Chief Executive Officer at 1322256 Alberta Ltd., Chairman at Targeted Molecules Corp., Chairman at Arbutus Biopharma Corp., Chairman at Allon Therapeutics, Inc., Director at Nventa Biopharmaceuticals Corp., Director at Medical Ventures Corp., Director at Chromos Molecular Systems, Inc., Director at Sophiris Bio, Inc. (2005-2010), Director at Neuromed Pharmaceuticals, Inc., Director at Gateway Casinos Income Fund, Director at Neuromed Pharmaceuticals Ltd., Director at Neovasc, Inc. (2005-2008), Director at Epiomed Therapeutics, Inc., and Professor at the University of British Columbia.
Dr. Miller received graduate and doctorate degrees from the University of Western Ontario.
Cargos activos de Jim J. Miller
| Empresas | Cargo | Inicio |
|---|---|---|
| Gateway Income Trust | Director/Miembro de la Junta | - |
| NDI Investment Management, Inc. | Presidente | 01/07/2001 |
Antiguos cargos conocidos de Jim J. Miller.
| Empresas | Cargo | Fin |
|---|---|---|
| SOPHIRIS BIO | Director/Miembro de la Junta | 19/11/2010 |
Neuromed Pharmaceuticals Ltd.
 Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC. | Director/Miembro de la Junta | 27/01/2010 |
| NEOVASC INC. | Director/Miembro de la Junta | 01/07/2008 |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Director Ejecutivo | 01/01/1991 |
| ARBUTUS BIOPHARMA CORPORATION | Presidente | - |
Formación de Jim J. Miller.
| University of Western Ontario | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| ALLON THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 15 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
Medical Ventures Corp.
 Medical Ventures Corp. Electronic Equipment/InstrumentsElectronic Technology Medical Ventures Corp. develops, manufactures and distributes medical devices and is focused on the development and commercialization of medical devices which clearly address a clinical need in the cardiovascular marketplace. The Company has two divisions: PMD tissue products used in cardiac reconstruction and repair and Angiometrx catheter products for the rapidly growing interventional cardiology market. The focus in both divisions is the commercialization of the cardiovascular medical devices currently in the MEV’s product portfolio and the development of new products based upon these two core technologies. The company is located in Richmond, Canada. | Electronic Technology |
1322256 Alberta Ltd.
 1322256 Alberta Ltd. Pharmaceuticals: MajorHealth Technology Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. | Health Technology |
Chromos Molecular Systems, Inc.
 Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Health Technology |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA. | Health Technology |
Targeted Molecules Corp.
 Targeted Molecules Corp. Miscellaneous Commercial ServicesCommercial Services Targeted Molecules Corp. is a biopharmaceutical company. It discovers and commercializes targeted drug therapies for a broad range of ailments including cancer and diseases of the central nervous system (CNS). Targeted Molecules was founded in 2000 and is located in San Diego, CA. | Commercial Services |
Neuromed Pharmaceuticals, Inc.
 Neuromed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals, Inc. develops new and improved pain medicines. It has multiple programs aimed at addressing this important unmet medical need. Its lead product candidate, ExalgoTM is an extended release formulation of hydromorphone in phase 3 clinical development. Neuromed is also developing oral drug candidates to block N-type and T-type calcium channels, an important target directly involved in pain signaling, and includes candidates for potentially treating pain, epilepsy and hypertension. | Health Technology |
Gateway Casinos Income Fund
 Gateway Casinos Income Fund Hotels/Resorts/Cruise linesConsumer Services The principal activity of the Group is to operate casinos in Western Canada. The Group operates seven casinos, six in British Columbia and one in Alberta. The operations of the Group are carried on through 3004 slot machines and electronic games and 118 table games. | Consumer Services |
Neuromed Pharmaceuticals Ltd.
Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC. | Health Technology |
NDI Capital, Inc.
 NDI Capital, Inc. Investment ManagersFinance NDI Capital, Inc (NDI Capital) is a venture capital firm Founded in 2003 and headquartered in Vancouver, British Columbia. | Finance |
Neovasc, Inc.
 Neovasc, Inc. Medical SpecialtiesHealth Technology Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada. | Health Technology |
| NDI Investment Management, Inc. | |
| Gateway Income Trust | |
Epiomed Therapeutics, Inc.
 Epiomed Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Epiomed Therapeutics, Inc. operates as a development stage pharmaceutical organization which focuses on the discovery, development and partnering of novel anti-emetic compounds for both the human and veterinary markets. The company was founded by David Reed Helton, Ernest H. Pfadenhauer and Richard P. Burgoon Jr. in October 2010 and is headquartered in Irvine, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jim J. Miller